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(57) ABSTRACT
A methodoftreating motor deficits in a stroke patient, com-
prising assessing a patient’s motor deficits, determining
therapeutic goals for the patient, based on the patient’s motor
deficits, selecting therapeutic tasks based on the therapeutic
goals, performing each of the selected therapeutic tasks
repetitively, observing the performance of the therapeutic
tasks, initiating the stimulation ofthe vagus nerve manually at
approximately a predetermined moment during the perfor-
manceofthe therapeutic tasks, stimulating the vagus nerve of
the patient during the performanceofthe selected therapeutic
tasks, and improving the patient’s motordeficits.
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METHODS, SYSTEMS, AND DEVICES FOR
PAIRING VAGUS NERVE STIMULATION
WITH MOTOR THERAPYIN STROKE
PATIENTS
CROSS-REFERENCE TO RELATED
APPLICATIONS
This application claims the benefit of U.S. Provisional
Patent Application No. 61/699,470, filed Sep. 11, 2012, U.S.
Provisional PatentApplication No. 61/614,369,filed Mar. 22,
2012, U.S. Provisional Patent Application No. 61/598,185,
filed Feb. 13, 2012, U.S. Provisional Patent Application No.
61/558,287,filed Nov. 10, 2011, and U.S. Provisional Patent
Application No. 61/627,532,filed Oct. 13, 2011. This appli-
cation is also a Continuation-In-Part of U.S. patent applica-
tion Ser. No. 13/095,570,filed Apr. 27, 2011, which claims
the benefit ofU.S. Provisional PatentApplication No. 61/328,
621, filed Apr. 27, 2010 and which is a Continuation-In-Part
ofUS. patent application Ser. No. 12/485,040,filed Jun. 15,
2009, which claims the benefit of: U.S. Provisional Patent
Application No. 61/077,648, filed Jul. 2, 2008; U.S. Provi-
sional Patent Application No. 61/078,954,filed Jul. 8, 2008;
US. Provisional Patent Application No. 61/086,116, filed
Aug. 4, 2008; and U.S. Provisional Patent Application No.
61/149,387, filed Feb. 3, 2009. All of these applications are
incorporated herein by reference as if reproduced in their
entirety.
STATEMENT REGARDING FEDERALLY
SPONSORED RESEARCH OR DEVELOPMENT
Notapplicable.
REFERENCE TO A MICROFICHE APPENDIX
Notapplicable.
BACKGROUND
Stroke is a leading cause of adult disability in the United
States, with upper motordeficits being the primary result of
the disability. These motor disabilities greatly affect quality
oflife for the patient andtheir loved ones. In addition, the loss
of motor function exacts a financial toll on the healthcare
system ofnearly $70 billion yearly. Patients with hemiplegia
or hemiparesis generally regain walking without the use ofan
assistive device while only halfto one-thirdofpatients regain
some degree ofuse oftheir upper extremity, even after inten-
sive rehabilitation therapy. The severe functional impairment
affects occupational performance, andas a result, few stroke
victimsare able to return to work. Upperlimb motordisabili-
ties from stroke have an unfavorable effect on the activities of
daily living critically affecting the quality oflife for the stroke
victim as well as family members andcaregivers.
Physical rehabilitation can result in significant improve-
ments in motor outcomes after stroke. Improvements in
recovery ofupper extremity function have also been reported
for electromyographic feedback, motor imagery, robotics,
and repetitive task practice, though large scale clinical trials
have yet to be implemented. Unfortunately for most patients,
the gains are not enoughto havea large impact on daily living.
Further, current rehabilitative therapies, such as constraint-
induced movementtherapy, are restricted to individuals with
mild to moderate deficits. Few optionsare available for those
stroke survivors with moderate to severe deficits. Therefore,
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there is still a tremendous need for methods that improve
recovery of function even further.
To enhance recovery further, adjuvant therapies have been
tried. For example, amphetaminescan be effective at enhanc-
ing recovery ofmotor abilities beyondthat seen with physical
rehabilitation alone; however, even the positive results for
motor outcomesare only incremental, and amphetamine use
has many well-knownside effects. Several small, randomized
controlled trials have shownthat epidural stimulation signifi-
cantly improves motor recovery in animal models and in
humanstroke survivors. Unfortunately, the method requires
brain surgery associated with the potential for significant
complications andis notlikely to reach widespread clinical
use in stroke patients. Also, a recent randomizedclinicaltrial
failed to demonstrate improvedefficacy comparedwith inten-
sive physical rehabilitation.
Less invasive methods for cortical stimulation have also
been combined with physical rehabilitation. Again, however,
while real gains in function are observed, the gains are mod-
est, for the most part. Thus, a great need still exists for a
method to improve motor function further.
Current rehabilitation techniques do not sufficiently
restore lost function in manyindividuals.Statistically signifi-
cant improvements to motor deficits can be induced even
several monthsafter stroke. However, these improvements do
not consistently improve quality oflife for the vast majority of
patients and their caretakers, thus greater improvements in
motorskills are needed following rehabilitation.
Motor therapies typically involve practicing either fine
motoror gross motorskills Repetition is generally the mecha-
nism of the therapies. In some variations, such as constraint
therapy and minortherapy, other mechanisms are engaged.
Some examples of typical motor therapies may be actions
such as: squeezing a dynamometer, turning on/off a light
switch, using a lock and key, opening and closing a door by
twisting or depressing different doorknobs, flipping cards,
coins and other objects over, placing light and heavy objects
at different heights, moving pegs to hole and remove pegs
from hole,lifting a shopping basket/briefcase, drawing geo-
metric shapes, dressing, typing, reaching and grasping light
and heavy objects, grasping andlifting different (size, shape,
and texture) objects, doing a precision grasp, writing, draw-
ing connect the dots, opening and closing a jar or medication
bottle, lifting an empty andfull cup/glass, using feeding uten-
sils, cutting food,stirring liquids, scooping, pouring aglassof
water with the paretic hand; or using the paretic hand to
stabilize the glass and pouring with the good hand, picking an
object and bring to target, using a spray can, cutting with
scissors, or brushing teeth/hair.
USS. Pat. No. 6,990,377 (Gliner, et al.) describes a therapy
to treat visual impairments. The therapy includes presenting
various types of visual stimuli in conjunction with stimula-
tion ofthe visual cortex. The therapy described in Gliner does
not control the timing relationship of the stimuli and the
stimulation.
USS. Patent Application Publication 2007/1079534 (Firlik,
et al.) describes a therapy having patient interactive cortical
stimulation and/or drug therapy. The therapy has patients
performingtasks, detecting patient characteristics and modi-
fying the stimulation depending on the detected patient char-
acteristics. The therapy described in Firlik does not control
the timing relationship between the tasks and the cortical
stimulation.
It is commonin the prior art to suggest that stimulation of
the cortex, the deep brain, the cranial nerves and the periph-
eral nerves are somehow equivalent or interchangeable to
producetherapeutic effects. Despite these blanket statements,
US 8,700,145 B2
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stimulation at different parts of the nervous system is not
equivalent. It is generally understoodthat the vagus nerveis a
nerve that performs unique functions through the release of a
wide array of neuromodulators throughout the brain. To gen-
erate certain kindsofplasticity, the timing of the stimulation
ofthe vagus nerveis critical in producing specific therapeutic
effects.
USS. Pat. No. 6,104,956 (Naritoku, et al.) is representative
ofwork done using vagus nerve stimulation (VNS)to treat a
variety of disorders, including epilepsy, traumatic brain
injury, and memory impairment. The VNSis delivered with-
out reference to any other therapy. To improve memory con-
solidation, VNSis delivered several minutes after a learning
experience. Memory consolidation is unrelated to the present
therapy for treating motordeficits.
SUMMARY
For purposes of summarizing the disclosure, certain
aspects, advantages, and novel features ofthe disclosure have
been described herein.It is to be understood that not neces-
sarily all such advantages may be achieved in accordance
with any particular embodimentofthe disclosure. Thus, the
disclosure may be embodied or carried out in a mannerthat
achieves or optimizes one advantage or group of advantages
as taught herein without necessarily achieving other advan-
tages as may be taught or suggested herein.
In an embodiment, the disclosure includes a method of
treating motordeficits in a stroke patient, comprising assess-
ing a patient’s motor deficits, determining therapeutic goals
for the patient, based on the patient’s motordeficits, selecting
therapeutic tasks based on the therapeutic goals, performing
each ofthe selected therapeutic tasks repetitively, stimulating
the vagus nerve of the patient during the performance of the
selected therapeutic tasks, and improving the patient’s motor
deficits.
Ina second embodiment, the disclosure includes a method
of treating motor deficits in a stroke patient, comprising
assessing a patient’s motordeficits, determining therapeutic
goals for the patient, based on the patient’s motor deficits,
selecting therapeutic tasks based on the therapeutic goals,
performing each ofthe selected therapeutic tasks repetitively,
observing the performanceofthe therapeutic tasks, initiating
the stimulation ofthe vagus nerve manually at approximately
apredeterminedmomentduring the performanceofthe thera-
peutic tasks, stimulating the vagus nerveofthe patient during
the performance of the selected therapeutic tasks, and
improving the patient’s motordeficits.
Ina third embodiment, the disclosure includes a method of
treating motordeficits in a stroke patient, comprising assess-
ing a patient’s motor deficits, determining therapeutic goals
for the patient, based on the patient’s motordeficits, selecting
therapeutic tasks based on the therapeutic goals, performing
each of the selected therapeutic tasks repetitively, detecting
the performance of the therapeutic task, automatically initi-
ating vagus nerve stimulation at a predetermined moment
during the detected performance of the therapeutic task,
stimulating the vagus nerveofthe patient during the perfor-
mance ofthe selected therapeutic tasks, and improving the
patient’s motordeficits.
In a fourth embodiment, the disclosure includes a system
for providing therapy for a motor deficit, comprising, an
implantable stimulation system including an implantable
pulse generator (IPG), lead and electrodes to stimulate a
patient’s vagus nerve,a clinical controller with stroke therapy
software, an external communication device to communicate
between the clinical controller and the implantable stimula-
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tion system, anda manualinput device, coupled to the clinical
controller, wherein the manual input device is engaged during
performanceof a therapeutic task causing the clinical con-
troller to send a signal using the external communication
device to the implantable stimulation system, so that a
patient’s vagus nerve is stimulated during the performance of
the therapeutic task.
Ina fifth embodiment, the disclosure includes a system for
providing automated therapy for a motordeficit, comprising,
an implantable stimulation system including an IPG, lead and
electrodes to stimulate a patient’s vagus nerve, a clinical
controller with stroke therapy software, an external commu-
nication device to communicate betweenthe clinical control-
ler and the implantable stimulation system, and a motion
detection system, coupled to the clinical controller, wherein
the motion detection system detects performanceofa thera-
peutic task and at a predetermined time during the therapeutic
task causing the clinical controller to send a signal using the
external communication device to the implantable stimula-
tion system, so that a patient’s vagus nerve is stimulated
during the performanceofthe therapeutic task.
These andother features may be more clearly understood
from the following detailed description taken in conjunction
with the accompanying drawings and claims.
BRIEF DESCRIPTION OF THE DRAWINGS
For a more complete understandingofthis disclosure, ref-
erence is now madeto the following brief description, taken
in connection with the accompanying drawings anddetailed
description, wherein like reference numerals represent like
parts.
FIG.1 is a flowchart depicting a task selection and therapy
parameter selection process for a paired-VNS motortherapy,
in accordance with an embodiment;
FIG. 2 is a flowchart depicting a setup and administration
process for a paired-VNS motortherapy, in accordance with
an embodiment;
FIG.3 is a flowchart depicting another setup and adminis-
tration process for an automated paired-VNS motor therapy
protocol, in accordance with an embodiment;
FIG. 4 is a graph depicting the timing of a therapeutic
motion and examples of possible stimulation timing varia-
tions for paired VNS;
FIG. 5 depicts an implantable vagus nerve stimulation
system, in situ, in accordance with an embodiment;
FIG.6 is a functional block diagram depicting a paired-
VNSmotor therapy system including a manual VNSswitch,
in accordance with an embodiment;
FIG. 7 is a functional block diagram depicting an auto-
mated paired-VNS motortherapy system, in accordance with
an embodiment;
FIG. 8 is a screenshot of an initial interface screen, in
accordance with an embodiment;
FIG.9 is a screenshot of a therapy information screen, in
accordance with an embodiment;
FIG. 10 is a screenshot of a stimulation parameter input
screen, in accordance with an embodiment;
FIG. 11 is a screenshotof a therapy input screen, in accor-
dance with an embodiment;
FIG. 12 is ascreenshotofan IPG parameterinput screen, in
accordance with an embodiment;
FIG. 13 is a screenshot of a therapy delivery screen, in
accordance with an embodiment;
FIG. 14 is a schematic diagram of an automated pairing
system, in accordance with an embodiment; and
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FIG.15 is a screenshot of an automated therapy screen, in
accordance with an embodiment.
FIG. 16 is a block diagram depicting a response control
system, in accordance with an embodiment;
FIG. 17 is a graph depicting response pairing, in accor-
dance with an embodiment;
FIG.18is a block diagram depicting a closed loop control
system, in accordance with an embodiment; and
FIG. 19 is a graph depicting closed loop pairing, in accor-
dance with an embodiment;
DETAILED DESCRIPTION
Tt should be understoodat the outset that although an illus-
trative implementation of one or more embodimentsare pro-
vided below, the disclosed systems and/or methods may be
implemented using any numberof techniques, whether cur-
rently knownor in existence. The disclosure should in no way
be limited to the illustrative implementations, drawings, and
techniquesillustrated below,including the exemplary designs
and implementations illustrated and described herein, but
may be modified within the scope of the appended claims
along with their full scope of equivalents. The present appli-
cation describes several embodiments, and noneofthe state-
ments below should be taken as limiting the claims generally.
Where block diagrams have been used to illustrate the
embodiments,it should be recognized that the physical loca-
tion where described functions are performed are not neces-
sarily represented by the blocks. Part of a function may be
performed in one location while another part of the same
function is performed at a distinct location. Multiple func-
tions may be performedat the samelocation. In a functional
block diagram, a single line may represent a connection, in
general, or a communicable connection, particularly in the
presence of a double line, which may represent a power
connection. In either case, a connection maybe tangible, as in
a wire, or radiated, as in near-field communication. An arrow
maytypically represent the direction of communication or
poweralthough should not be taken as limiting the direction
of connected flow.
Therapy
VNSis paired with a motortherapy by providing the stimu-
lation at sometime during the motortherapy, for example, the
beginning of the motion. Because the cortical plasticity is
generated by the stimulation for a short time period, as short
as a few seconds, the VNSshould be providedso that most of
the VNSis during the motions that constitute the therapy.
With reference to FIG. 1, a flowchart 100 depicts a task
selection and therapy parameter selection process for a
paired-VNS motor therapy 100, in accordance with an
embodiment. The process 100 begins with a patient evalua-
tion at 102. The patient evaluation may include a standard
medical evaluation, medical history, and assessment of the
patient’s motordeficit. Persons of ordinary skill in the art are
aware of other information that can be included in a patient
evaluation. The patient’s motor deficit or handicap may be
assessed using standard motor deficit assessment criteria,
such as Fugl-Meyer, Barthel Index, Box and Block Test,
Canadian Occupation Performance Measure (COPM), Func-
tional Independence Measure (FIM), Motor Assessment
Scale (MAS), Action Research Arm Test (ARAT), Modified
Rankin Scale, Nine hole peg test, NIH Stroke scale, Stroke
Impact Scale (SIS) or any other appropriate assessment mea-
sures.
10
30
40
45
6
The process 100 may continue with setting the therapeutic
goals at 104. Therapeutic goals may include such things as
tying shoes, unlocking doors, eating, or performing other
basic life tasks. Persons of ordinary skill in the art are aware
of other types of goals.
Taking into consideration the therapeutic goals, a set of
tasks are selected at 106 that either address specific muscle
groups necessary to achieve the therapeutic goals, mimic the
basic life tasks, or mimic someportion of those tasks. For
example, ifthe goalis to be able to unlock a door, then the task
ofinserting a key and turning the key in a lock maybeselected
as a task. On the other hand, if the patient is suffering from
moreserious disabilities in this regard, then the task ofreach-
ing and grasping an object maybeselected, as afirst step
toward the task of unlocking a door.
Tasks may include: Reach and grasp; Lift objects from
table; Circumduction and bimanual tasks (mainly involving
wrist and distal joints); Stacking objects; Slide credit card in
slot; Turning on and off light switch; Squeezing objects;
Writing; Typing; Stirring liquid in a bow] (bimanual); Dial a
cell phone (bimanual); Fold towels or clothes (bimanual);
Weara belt; Tying shoelaces; Eating; Brushing teeth; Comb-
ing hair.
Eachofthe tasks is defined with a spectrum oflevels. The
task of moving a weight, for example, may include smaller
weights and larger weights. Given a patient’s abilities and the
therapeutic goals, the initial task level is selected at 108. The
patient may begin performingthetask at the selected level. As
the therapy proceeds,the level ofthe task may be changed to
reflect changesin the patient’s ability to perform the task. Ifa
patient becomes adept at performing a task at the selected
level, the level may be increased. If the patient struggles to
perform the task at a given level, the level may be decreased.
Each taskmay be repeated manytimes. Ina typical therapy,
a task may be repeated from about 30 to about 50 times in a
session. The numberofrepetitions for each task is selected at
110. The stimulation parameters for the vagus nerve stimula-
tion, such as the amplitude, pulse width, the duration of the
pulse train, frequency, and train period are selected at 112.
With reference to FIG. 2, a setup and therapy delivery
process 200 is shown. The physical items necessary for a
selected task may be setup in the appropriate therapy spaceat
202. The task and task parameters, such as what counts as
success, are explained to the patient at 204. The task delivery
softwareis used to control the delivery of stimulations and to
record data at 206. When the patient is instructed that the
therapy has begun,the patient performsthefirst selected task
at 208, in accordance with the instructions given. At approxi-
mately a determined point in the performanceofthetask, the
manual input device is used to cause the vagus nerve of the
patient to be stimulated at 210. Typically, the vagus nerveis
stimulated with a 500 millisecond pulse train at approxi-
mately 0.8 milliamperes. The 500 millisecond duration has
been selected as sufficient to generate directed plasticity.
Experiments have shown that a 500 millisecond stimulation
generates directed plasticity that lasts less than 8 seconds.
While longer pulse trains may be effective, the shorter dura-
tion is typically preferred because the shorter stimulation
leads to less side effects. Following stimulation at 212, there
is a period of non-stimulation, which maybeat least as long
as the preceding period of stimulation. The period of non-
stimulation may be a safety measure and maybepart of the
therapeutic process. When the task has been completed, the
task level may be evaluated at 214, to determine if the task
level is too simple or too advanced for the patient. The task
level may be changedat this point, as appropriate. The patient
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then performsthe task again at 208 until the task has been
repeated a predetermined numberoftimes.
With reference to FIG. 3, a setup and automated therapy
process 300 is shown. The physical items necessary for a
selected task may be setup in the appropriate therapy space at
302. The setup may includeinitiating software to administer
the automation. The task and the task parameters, such as
what counts as success, are explained to the patient at 304.
The task delivery software is used to control the delivery of
stimulations and to record data at 306. When the patient is
instructed that the therapy has begun,the patient performsthe
first selected task at 308, in accordance with the instructions
given. A clinical control device detects task performanceat
310. Cameras or other sensors may be used for to detect the
patient’s movements. At a determined point in the perfor-
manceofthe task, the control device causes the vagus nerve
of the patient to be stimulated at 312. Following stimulation,
there is a period of non-stimulation at 314, which may be at
least as long as the preceding period of stimulation. The
period of non-stimulation may be a safety measure and may
be part of the therapeutic process. When the task has been
completed, the task level may be evaluated at 316, to deter-
mine if the task level is too simple or too advanced for the
patient. The task level may be changedatthis point, as appro-
priate. The patient then performsthe task again at 308 until
the task has been repeated a predetermined numberoftimes.
With reference to FIG. 4, a graph depicts the timing of the
therapeutic task and examples of vagus nerve stimulation
timing. Before a motion begins, the patient forms a mental
intention and soon after, the motion begins. The task may
typically include a series ofmotions. For example, a task may
include, reaching, grasping, moving,releasing, and returning.
Between each ofthese motionsis a transition pointor step that
maybe usedto timethe stimulation. Finally, the motion ends.
The vagus nerve stimulation may be effectively delivered
at various times during the therapeutic task. For example,line
a showsa vagusnerve stimulation givenafter the intention to
moveis formed and before the motion begins. Line b shows a
vagus nerve stimulation delivered after the motion begins.
Line c showsa vagus nerve stimulation deliveredafter a first
transition pointor step in the therapeutic task. Line d shows a
vagus nerve stimulation delivered after a second transition
point or step in the therapeutic task. Line e shows a longer
vagus nerve stimulation delivered between the time the
motion starts and shortly after the motion ends. The extended
stimulation duration shown at line e may be a single long
pulse train ora series ofhalf-secondpulsetrains. Line fshows
three vagus nerve stimulations delivered during the therapeu-
tic task, after the motion begins, after the first step and after
the second step. Any of these VNS delivery methods may be
used singularly or in combination.
Other systems may be used to monitor movements, so that
appropriate VNStiming can be determined. For a wrist flex-
ion, we might use a camera to model the movementas a wire
frame(e.g., bones with joints) and compare the movementto
past attempts andto optimal(e.g., normal) movementin order
to find the best movements that the patient can generate.
Movements, suchas walking, grasping or tying, may be quan-
tified as location, direction, speed, and angle of each joint as
a function of time. For speech production, vocalizations
might be compared to previous sounds and normal speech
sounds producedby others. Vocal movements might be quan-
tified based onthe intensity, duration, pitch, formantstructure
(vowels), formant transitions (consonants), voice-onsettime,
and other standard methods of quantifying speech sounds.
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Selecting the appropriate paired VNS period depends on
the nature of the motion and the equipmentused to provide
the pairing timing.
VNScould also be delivered during the planning stages
before movementbegins. This usually takes only a few hun-
dred milliseconds but canbe extended by giving a sensory cue
that instructs the subject what motion needs to be donefol-
lowedby a trigger cue some secondslater telling them when
to begin the movement. This strategy makes it possible to
specifically pair VNS with motor planning, which is an
important part of motor control.
VNS maybepaired with the best movements in order to
shape future movements to be smooth andefficient (e.g.,
avoid spasticity, tremors, co-contraction of opposing
muscles, or the use of muscles that would not normally be
used to accomplish the task). VNS could also be delivered
after the movement is completed and determinedto be effec-
tive (e.g., the best movementofthe attempts occurring in the
last about 30 seconds).
Thus, VNS could be delivered before, during, or after
movement.Ameasurement may showthat the movementwill
be, is, or was effective (e.g., acceptable or better than aver-
age). Pairing may mean temporally associated with, not nec-
essarily simultaneous. For the rat study discussed below,all
VNSwasdelivered after the end of the target movement.
However, in manycases, the rats continue with the movement
after the target movementis achieved such that VNSis some-
time delivered while the rat is moving.
VNS may be paired with supervised, massed practice
movementtherapy three times per week. The duration of the
therapy may be six weeks. The duration of each therapy
session may be approximately one hour. The therapist may
determine each session’s therapy tasks to progress toward the
Canadian Occupational Performance Measure (COPM)
goals establishedat the intake evaluation. Goals may focus on
upper limb rehabilitation—most tasks may typically require
four movement components: reaching, grasping, manipulat-
ing, and releasing an object. During each session the ‘primary
therapy principles’ may be used to guide the developmentof
the tasks to be performed each day.Prior to each therapyvisit,
the therapist team may meetand developthe task plan, ensure
available materials and determine the plan to increase and
decrease difficulty to and determine a realistic number of
repetitions to be set as a goal.
The therapy implements several principles. The first prin-
ciple is task specificity. Improvementofa motorskill requires
practice of the movement; thus, each task may include com-
ponents of reach, grasp, manipulate, and release specifically
related to the target task.
Anothertherapy principle is that ofrepetition. Large num-
bers of repetitions of each task is required to master a motor
skill, so the goal for therapy is to perform from about 30 to
about 50 repetitions of a given task in a one-hour session
(about 120-about 200 total repetitions per session). The focus
of each therapy session may involve from about 3 to about 5
tasks in order to achieve the high numbersof repetitions.
Another therapy principle is active engagement. Optimal
learning occurs with high levels of motivation and engage-
ment. Thus, participants mayhelp to set goals, therapists may
make it clear how the target task relates to each goal, task
practice may be varied to minimize boredom, and the task
may be constantly adapted to require active engagement and
effort to complete.
Another therapy principle is massed practice. Within a
session, massed practice promotes better learning than dis-
tributed practice. Thus, the therapeutic environment needsto
allow continuousrepetition. For example, therapist may line
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up 10 objects in a row to allow for continued repetition. Rest
breaksare given only ifrequested by thepatient or requiredby
the VNS.
Another therapy principle is variable practice. Variable
practice can be importantfor learning transfer. The movement
components may stay the same, and the context of the com-
ponents may change betweentrials or sessions.
Thetherapy session should consist offrom about 3 to about
5 tasksto allow variability and patient engagement.A reach&
grasp task may be included in each session. The majority of
patients need work in this area, so includingit as a required
task allows for consistency between patients and useful in
judging rehabilitation with assessments.
The therapy session may,atleastinitially, take place under
the supervision of one or more therapists. The patient may
perform the action without assistance from the therapist. The
therapist may manually deliver the VNStrigger during the
“key” part of the movement that is being trained (typically
whenthe subject touchesor is about to touch the object during
the reach). Alternatively, automatic delivery could be used.
Tasks may be appropriately gradedto require processing and
effort by the patient but some degree of success. As a general
guideline, if the patient is unable to complete the task suc-
cessfully after approximately five attempts, it should be
downgraded in difficulty. This guideline may be superseded
by the therapist’s clinical judgment regarding the patient’s
motivation, ability, and fatigue. If the patientis able to com-
plete the task with little difficulty approximately (e.g., from
about 10 to about 20 times) it should be upgradedin difficulty.
Ifthey can completeit, but it is slower than normal, then it is
still a challenging task, and variety may needto be introduced
to alleviate boredom.
The upgrading and downgrading oftasks is dependent on
the patient’s goals as well as the effort required. The level of
strength and endurance required forthe goalis also an impor-
tant consideration. For somepatients, even higher repetitions
maybe required to achieve the endurance needs. The goal for
repetitions of each task may be set ahead of time by the
therapist and communicatedto the patient.
Grading oftasks can involve several different components:
Physical position of the patient. The patient may be standing
to introduce variety, add endurance, and add balance compo-
nents to the task performance. Alternatively, the patient may
be sitting.
The position of the task materials may be changed. The
height ofthe task materials may be changed. The depth ofthe
task materials, placing the materials further away from
patient, may be changed. The degree from midline of objects
(eft, midline, or right) may be varied. The weight of task
materials may be changed. The size of the objects may be
changed.
Adaptive equipment/materials may be used. A DYCEM
matmay be used to prevent an item from sliding. The therapist
may hold item to stabilize it. Materials may be used to
increase the grip of a small object to match ability (e.g., use
foam to build up a pen to makeit easier to grasp).
The speed of task movement may be changed. A certain
numberof repetitions per minute may be implemented to
focus on the speed ofmovement. The patient may be encour-
aged to slow down task performance.
Thestability of the object may be changed. The object to
grasp maybe stable. The object to grasp may be moving(e.g.,
a ball is rolling on a table). The object may be placed on
slippery surface or a sticky surface.
The same task can be practiced with different forms of
material to achieve variety but still maintain high levels of
repetition of the overall task. For example, to work on grasp
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and release of small objects, a plethora of everyday objects
could be used, such as coins, paperclips, credit cards, cell
phones, etc.
Task performance may be monitored by the therapist, and
each VNSstimulation may be recorded by the software and
presented to the therapist as a visual counter on the screen.
If in the therapist’s assessment there are other rehabilita-
tion issues that may require intervention, such as restricted
range of motion, this can be addressed outside of the about
one hour motorpractice or addressedpriorto the start of the
VNStherapy. Ifthere are significant non-motor impairments,
such maydisqualify the participant. Patients may not be given
a homeexercise program of specific items to practice. How-
ever, they maybetold to participate in their normal every day
activities and be encouragedto “practice using your impaired
upper extremity as muchas possible”.
EXAMPLES OF GOAL AND TASK GRADING
Example 1
Grasp and Release. The patient’s goal is to be able to
unload dishwasher. The target task involves the ability to
grasp, manipulate, andrelease a variety of objects along with
a variety of strength and range of motion requirements and
some degree of endurance (e.g., being able to stand for the
entire duration).
Materials: spoon, fork, knife, large serving spoon, large
and medium mixing bowl, coffee mug, drinking glass, small
plate, large dinner plate, a DYCEM mat, foam.
Method:First, Patient sits at table with objects at midline
Second, for each task repetition, the patient reaches out to
grasp object and place on shelf aboutsix feet abovethe table.
Third, 10 objects are lined up to allow continuousrepetition
of the movementand achieve high numbers.
Grading: The task can be upgraded in difficulty by: chal-
lenging patient that a certain numberofrepetitions be com-
pleted in one minute; using a variety of sizes instead of the
same size/shape in a row; requiring the patient stand to per-
form; requiring the patient bend downto retrieve the object;
requiring the patient reach higher to place the object; requir-
ing the patient sort and place each object in the correct posi-
tion in a drawer; mixing bilateral lifting with single hand
tasks; silverware is placed in a basket to be removed from;
weight baring is requiredin onelimb to stabilize during a task
(e.g., the patient leans on his less affected arm and practices
wiping the table with the impaired arm); and/or including
bilateral tasks that aren’t symmetrical(e.g., the patient uses a
spray bottle with the impaired hand and cleans with the less
affected arm).
The tasks can be downgradedin difficulty by: wrapping the
object in foam to makeit easier to grasp; placing objects on a
DYCEM mat to minimize slipping; requiring object be
moved from impaired hemifield to less impaired hemifield;
and/or performingbilateral tasks.
Introducing variety and still achieving high numbers of
repetitions. First, the goal for this task is 200+ repetitions.
Since the goal is a complextask that involves several compo-
nents this may be the only task performed is this session.
Second, for the first part of the session, the task may be
designed to primarily challenge the grasp. The individual
maygrasp objects in a variety of challenging ways with less
challenge focused on the reach or manipulate aspect of the
entire task, for 100 repetitions (e.g., 10 objectsx10 repeti-
tions) This may take about 25 minutes. There is a line of
objects set up, thus there may be very little rest between
repetitions. The second part may have greater emphasis onthe
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reach part of the task, but the task is still repeating the com-
ponents. The individual may now pick up arelatively easy
object, that is further away from him, requiring a reach to
different aspects of the field in front of him. Each of these
trials may take longer. He may perform 35 trials of this from
a variety of reach locations, which may require approxi-
mately 15 minutes. For variety, the object could be close and
the he would be required to reach atthe limits ofhis ability for
the release of the object. Finally, the third part may focus on
manipulation and precision. For these trials, the initial grasp
and reach is notas difficult, but the manipulation/release may
berepeated, e.g. about 75 times in about 20 minutes. This may
require precise placement of an object (e.g., the participant
has to stack a set of spoons on top ofeach otheror place cups
in a precise stack. The day’s session was focused on the goal
with all repetitions were focused specifically toward the same
task, but different aspects of the goal were emphasized to
eliminate boredom andfatigue.
Example 2
Handwriting. The patient’s goal involves being able to
write checks and thank you notes.
Materials: pen, paper, pencil, dry erase board, cylindrical
foam, sandtray, shaving cream,andtray.
Method:First, the patient sits at a table with a tray with a
mound of shaving cream. Second, the patient practices
spreading the cream evenly throughout the tray. Third, the
patient practices free writing with a finger or with a stylus.
Fourth, the patient practices loop drawingor free writing with
writing utensil ofchoice. Fifth, the patient practicesfilling out
formsor line writing within constrained box.
Grading: The tasks can be upgraded in difficulty by:
increasing the numberofwords written (e.g., phone number,
address, sentences); decreasing task difficulty by using built
up writing utensils to aid in grip; and/or decreasing task
difficulty by using dry erase board, shaving cream, writing
largeletters or loops.
Example 3
Bilateral Activity. The patient’s goal involves folding laun-
dry.
Materials: 10 wash cloths, 10 hand towels, 10 bath towels,
10 t-shirts, 10 pairs of socks.
Method: First, the patient may sit or stand at the table.
Second, the patient may fold towels at midline. Third, all
towels may be folded in half and then in half again using
bilateral upper extremities. Fourth, folded towels may be
placed in laundry basket.
Grading: Tasks may be decreasedorincreasedin difficulty
by changing the size and weight of objects. Tasks may be
decreased or increased in difficulty by changing the number
of folds required in the object. Task can be increased or
decreased in difficulty by changing the location ofwhere the
object is to be grasped or placed. The therapist may unfold the
towels to allow rapid repeat of task.
Example 4
Fine Motor Tasks. The patient’s goal involvesfishing.
Materials: 10 fishing lures, various sized bobbers, fishing
weights, fishing line, a tackle box, anda fishing reel.
Method: First, The tackle box is placed at the patient’s
midline. Second, fishing weights bombers and lures are
placed on the affected side. Third, the patientis instructed to
pick up items and place them in the top box. Fourth, the
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patient is instructed to pick up items oneat a time.Fifth, the
patient practice is tying a fishing line. Sixth,the patient prac-
tices stabilizingthe fishing rodwith one hand andreeling with
the other hand.
Grading: Increase or decrease task difficulty by increasing
or decreasing the size of the items in the tackle box. Increase
or decrease the difficulty by increasing or decreasing the
weight of items at the end ofthe fishing line.
Example 5
A Discrete, Specific Task. The patient’s goal involves
opening doors.
Materials: A set of experimental doors knobs with various
types of locks, keys, and actual doors.
Method: First, the key is built up with foam or putty to
allow easier grasp of the key. Second, the knobs/locks are
placed at an easily accessible heightto allow the patientto sit
and perform the task. Third, actual doors are used and the
patient has to fully open the door and walk through.
Grading: A variety ofknob types are used requiring differ-
ent aspects of grasp. The knobs/locks are placed at progres-
sively more difficult positions. The actual doors are light or
heavy.
Systems and Devices
With reference to FIG. 5, an implantable vagus nerve
stimulation system 500 is shown in situ. The implantable
vagus nerve stimulation system 500 includes an IPG 506,
electrodes 502, and a lead 504 connecting the IPG 506 to the
electrodes 502. The IPG 506 may be implanted in the chest of
a patient 512. The lead 504 travels below the skin to the neck
of the patient 512. The electrodes 502 maybe ofthe cuff-
electrode type and maybe attachedto theleft vagus nerve 508
in the neck of the patient 512. The IPG 506 sendselectrical
stimulation pulses through the lead 504to the electrodes 502,
causing stimulation ofthe vagus nerve 508. The IPG 506, lead
504, and electrodes 502 function similarly to the implantable
vagus nerve stimulation systems commonly usedin the treat-
ment of epilepsy and as described in the parent patent appli-
cation to this application.
Vagus nerve stimulation may be delivered with electrodes
placed in direct contact (or proximate to) the left cervical
vagusnerve, in the patient’s neck. Other formsof stimulation
may be used, including transcutaneouselectrical or magnetic
stimulation, physical stimulation, or any other form of stimu-
lation. An example of a transcutaneouselectrical stimulation
system that could be adapted for use in the described therapy
maybe found in U.S. Pat. No. 7,797,042. Stimulation of the
vagus nerve may be doneat othersites along the vagus nerve
and branches of the vagus nerve.
With reference to FIG. 6, a stroke therapy system 600 is
shown. The implanted stimulation system 500 communicates
wirelessly with an external communication device 602. The
external communication device is coupled to a clinical con-
troller 604. The clinical controller 604 may be a computer,
such as a laptop computer, running specialized paired VNS
stroke therapy software. A manual input device 606 may be
coupled to the clinical controller 604. The manual input
device 606 may be a hand switch, a foot switch, a mouse
button, or a keyboard key. When the manualinput device 606
is switched or pressed, the clinical controller 604 sends a
signal to the external communication device 602. The exter-
nal communication device 602 sends a signal to the implanted
stimulation system 500. The implanted stimulation system
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500 receives the signal at the IPG 506 and generates stimu-
lation of the vagus nerve at the electrodes 502.
With reference to FIG. 7, a stroke therapy system 700 is
shown. The implanted stimulation system 500 communicates
wirelessly with an external communication device 602. The
external communication device is coupled to the clinical con-
troller 604, which may be coupled to manual input device
606. A camera 608 and sensor 610 may also be coupled to the
clinical controller 604. The camera 608 and/or sensor 610
detect motion orattributes ofthe motion. The data detected by
the camera 608 and/or sensor 610 are processed by the clini-
cal controller 604. When the data indicates a threshold has
been reached during the performanceofthe therapeutic task,
the clinical controller 604 may send a signal to the external
communication device 602, and the external communication
device 602 may send a signal to the implanted stimulation
system 500. The implanted stimulation system 500 receives
the signal at the IPG and generates stimulation of the vagus
nerveat the electrodes. The manual input device 606 may be
used to control the delay between stimulations.
The system may also implement magnet mode, where a
hand-held magnet may be swiped over the IPG in order to
cause a stimulation. The specialized stroke software may
include a magnet modesetting, to provide for use of this
mode. When in magnet mode, swiping the hand-held magnet
will deliver a pre-programmed stimulation (i.e. at whatever
settings were programmed). The reasonforthis feature is the
physician and patient do not need to be in proximity of the
computer/external controller, an arrangement that may work
better for some kinds of tasks. When not in magnet mode the
magnet causes stimulation to stop, as a safety feature.
The clinical controller 604 may run specialized stroke
therapy software. The specialized stroke therapy software
manages patient data, controls the stimulations, sets the
stimulation parameters, and records data from the therapy.
FIGS. 8-13 show screenshots from an embodiment of the
stroke therapy software. With reference to FIG. 8, a screen
shot showsaninitial page of the specialized stroke therapy
software. Theinitial page allowsthe user to navigate to input
screens for programmingthe implant, set the therapy param-
eters, and access patient data. With reference to FIG. 9, a
screen shot depicts the input screen for programming the
implantable system. With reference to FIG. 10, a screen shot
depicts an input screen for further programming the implant-
able system. With reference to FIG. 11, a screen shot depicts
an input screen for advancedsettings. With reference to FIG.
12, a screen shot depicts an input screen for implantable
parameters. With reference to FIG. 13, a screen shot depicts a
therapy delivery screen. On the therapy delivery screen, a
therapeutic task may be selected.
With reference to FIG. 14, an automated stimulation pair-
ing system 800 is shown. One or more objects 802 such as a
cylinder, a key, a block, or any other object suitable for
manipulation-type tasks is placed in a workspace.Portions of
the patient’s body, such as a handorfingers, may also serve as
objects. The object 802 is marked with a colored marker 804
such as a piece of colored tape, a spot of paint, a colored
sticker or any appropriate manner of marking an object with
color. For sometasks, such as rotation, the colored marker
804 needs a long edge and a short edge, as shown. Any object
802 can be marked with a sticker or tracking sphere and
trackedforthe therapy.A camera 608 ora plurality ofcameras
608 are placed around the workspace so that the object 802
and the marker 804 is within view ofthe camera 608. Cameras
608 may also be used to monitor the patient rather than an
object or marker. In accordance with an embodiment, a cam-
era may be placed above the workspace. The cameras 608 are
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connectedto the clinical controller 604. Specialized software
running on the clinical controller 604 uses data from the
cameras 608 to determinethe relative position, velocity, rota-
tion or any other metric related to the performance of the
given task. The clinical controller 604 uses the determined
metric to decide when stimulation is appropriate and sends a
stimulation signalto the external communication device 602.
A manualinterrupt 606 may be implementedso that a thera-
pist can interrupt and control the rate of stimulation. The
automated system 800 may be completely automated, in a
closed loop setup so that the next stimulation is automatic.
The automated system 800 maybe arranged in an open loop
fashion, so that the therapist must intercede before the next
stimulation.
The specialized software monitors x,y,z translations of
objects with an attached target. The specialized software
includes parameters for a variety of tasks that may be per-
formed using this type of closed loop automated system.
Using a single camera and colored markers, a wide variety of
tasks can be automated. Motion, speed, height, initiation of
translation, acceleration, angular rotation, angular velocity,
angular acceleration, force, velocity, acceleration, angular
acceleration, path length, time to target, distance traveled to
target, range ofmotion, height of object and combinations of
these and other metrics can be used to trigger stimulation.
Some example tasks include:slide a cup,lift a cup, spina cup,
Lift a cup and moveit to someother location, move an object
by rotating your wrist, turn a key,flip a coin, pick up a spoon.
Tasks may be combinations of movements or tasks, such as
lifting a cup and bring it to the mouth, lifting a penny and
putting it on a shelf, lifting a key, putting it in a lock and
turning the key,or sliding a cup to some point, picking it up,
and spinning it 30 degrees. The tasks may be designed to
isolate movements of specific muscle groups. Adaptive track-
ing of a base metric, based on past performance within a
session or betweensessions, can be used to generate improve-
ment.
The automatedpaired stimulation system may be arranged
so that when the object 802 is moved into or out of a pre-
defined boundary that surrounds the object, vagus nerve
stimulation is triggered.
A marker 804 can be placed on the patient’s hand or arm
rather than on an object.
Whenthe object 802 whenlifted or lowered in the z—axes
i.e. towards the camera 608, the change in the area of the
marker 804 may be detected and used totrigger stimulation.
The object 802 may be movedto specified places on the
surface. For example, the task may require the patient to move
the task object 802 to a square on the surface. Whenthe object
is successfully moved to the square, the VNSstimulation is
triggered.
Stimulation is triggered during the movements. The spe-
cialized software may stimulate on the best trials, such as
shortest path length, fastest movement, optimal acceleration,
minimaljitter, maximum height and other metrics, to provide
pairing with improved performance.
The manual interrupt 606 may be adapted to require the
therapist after a stimulation from the automatic software to
press the manual interrupt 606 to indicate a new stimulation
can be permitted. This allows the physician or patientto reset
the object 802 or for the physician to demonstrate the move-
ment without accidentally causing a stimulation.
In accordance with another embodiment, EMG (muscle
electrical activity) may be measured and used to trigger
paired vagus nerve stimulation.It is also possible to quantify
or image specific movementsofthe patient such as a patient’s
walking gait, eye position or tongue position and pair them
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with VNS. Muscle activity in muscle groups that are only
partly under voluntary control (e.g. bladder and sphincter)
may be usedto trigger paired vagus nerve stimulation.
The automated system may support such tasks as: Reach
and grasp; Reach and grasp (small/large objects) (gross and
fine movements, dexterity); Point and/or press objects with
finger (accuracy); Insert small objects into wells of different
sizes (accuracy); Flip cards or sheets of paper (Circumduc-
tion and dexterity); Lift objects from table; Circumduction
and bimanualtasks (mainly involving wrist and distal joints);
Lock and key (Circumduction); Turning a doorknob (Cir-
cumduction); Open andclose a pill bottle (bimanual; flexion
extension wrist); Pour water from a pitcher to glass (bi-
manual).
Motion can be detected using a camera or other detection
devices. The system may operate by detecting change in color
of the object by a camera, breaking an IR beam PIR motion
sensor, engaging a force transducer, turning a knob or dial
potentiometer, pressing a button, flipping a switch,activating
a motion sensor, activating a piezoelectric sensor, ultrasonic
sensors for detecting distance, or any other appropriate mea-
sure of motion.
The automated system may be designedto dois to deter-
mine a “good”trial and only stimulate on a goodtrial. A good
trial may be determined by comparing the history of past
movements, running an appropriate algorithm ona clinically
relevant parameter(s) and using this determinationto trigger
stimulation. Good could be defined ahead of time by speed,
acceleration, strength, range of motion, like degree of wrist
turn, or any other appropriate defining quality.
Similar automated systemsare described in U.S. Pat. Nos.
6,155,971 and 7,024,398.
With reference to FIG. 15, a screenshot of a specialized
automated pairing software is depicted. Patient data and
motion parameters may be entered or selected.A camera view
detects the motion of an object and provides vagus nerve
stimulation, in accordance with the selected parameters.
Support
Although sensory and motor systems support different
functions, both systems can exhibit topographic reorganiza-
tion of the cortex following training or injury. Tone training
(conditioning orartificial stimulation) can increase the rep-
resentation ofthe tone in the auditory cortex. Operanttraining
on atactile discrimination task increased somatosensory cor-
tical representation of the digit used in training. Similar
changes can occur in the motorcortex followingtraining with
precise digit movements. Motivation and frequency oftrain-
ing influence the degree of cortical map plasticity. Depriva-
tion caused by peripheral injury changes the organization of
sensory and motorcortices. For example, digit amputation or
nerve transection causes receptive fields in the inactivated
somatosensory cortex to shift to neighboring digits. Likewise,
transecting the facial nerve reduces the number of motor
cortex neuronsthat elicit vibrissae movements while increas-
ing the numbereliciting forelimb movements. Targeted
lesions to the sensory or motor cortex can cause the surround-
ing healthy cortical areas to take on some of the damaged
area’s lost functionality. Drugs that block reorganization of
cortical representations in the sensory cortex can also block
reorganization in the motorcortex. Collectively, these results
suggest that the mechanismsregulating cortical plasticity are
commonto both sensory and motorcortices.
The vagus nerve may send afferents to a numberofnuclei
known to release neuromodulators associated with cortical
plasticity, including the locus coreleus, raphe nuclei, and the
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basal forebrain. The vagus nerve has several efferents to
major organs in the body, includingthe heart; however, a large
portion ofthe vagus nerve consists of afferent connections to
several targets in the midbrain. Low-current stimulation of
the left vagus nerve is a commonly used treatment for drug-
resistant epilepsy that is associated with minimalrisks. Com-
plications associated with stimulation to the heart are avoided
due to the limited contributions of the left vagus nerve to
cardiac activity and the minimallevels of current. Unilateral
stimulation ofthe vagus nerve can result in bilateralactivation
of the nucleus of the solitary tract and its projections to the
locus coeruleus and raphe nucleus. Activation of the locus
coeruleus can lead to activation ofthe nucleusbasalis through
al adrenoreceptors. Although the exact mechanisms of
action are notentirely yet understood, VNS has demonstrated
several beneficial effects for major depression, mood
enhancement, improved memory, decision making, and
improved cognitive abilities in Alzheimer’s patients, and it
reduces edema following brain trauma. Due to the known
release of multiple neuromodulators, VNS has recently
becomean object of study in regulating cortical plasticity.
Pairing VNS with motor therapies can be accomplished
using several types of pairing systems. A timing control
device can initiate or provide the therapy and the VNSat
appropriate times. A timing control device can monitor the
therapy and provide VNS at appropriate times during the
therapy. A timing control device can receive manual inputs
from a patient or clinician during the therapy and generate
VNSat appropriate times.
Several experiments have been performed that demon-
strate the effectiveness of pairing motor therapy with VNS.
The methodsandresults of those experiments are described
below.
The wheel spin task required the rat to spin a textured
wheel towards themselves. Rats used movements ofthe wrist
and digits to complete this task. Stimulation and reward
occurred after the rat spun the wheel about 145° within about
one second period. The lever press task required the rat to
depressa spring-loadedlever twice within about 0.5 seconds.
The range of motion required to complete this task pivoted
primarily around the shoulder joint. Stimulation and reward
occurred after the secondleverpress.
Although sensory and motor systems support different
functions, both systems exhibit dependentcortical plasticity
under similar conditions. If mechanisms regulating cortical
plasticity are common to sensory and motor cortices, then
methods generating plasticity in sensory cortex should be
effective in motor cortex. Repeatedly pairing a tone with a
briefperiod ofVNSincreasesthe proportion ofprimary audi-
tory cortex respondingto the paired tone.It was predicted that
repeatedly pairing VNS with a specific movement would
result in an increased representation of that movement in
primary motor cortex. As such, VNS waspaired with move-
ments of the distal or proximate forelimb in two groups of
rats. After about five days ofVNS movementpairing, intrac-
ranial microstimulation wasused to quantify the organization
of primary motor cortex. Larger cortical areas were associ-
ated with movements paired with VNS.Rats receiving iden-
tical motor training without VNS pairing did not exhibit
motor cortex mapplasticity. These results suggest thatpairing
VNSwith specific events may act as a general method for
increasing cortical representations of those events. VNS-
movement pairing could provide a new approachfortreating
disorders associated with abnormal movement representa-
tions.
Repeatedly pairing VNS with a tone may cause a greater
representation of that tone in primary auditory cortex. This
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map expansion is specific to tones presented within a few
hundred milliseconds of VNS. No previous study has
reported the effects ofpairing VNS with a specific movement
on cortical plasticity. Ifthe mechanismsregulating map plas-
ticity in the auditory cortex are the samein the motorcortex,
thenVNS-paired with a movement should generate mapplas-
ticity specific to the paired movement. In one embodiment,
VNSwas paired with a specific movementto test if this
method could be usedto direct specific and long-lasting plas-
ticity in the motorcortex.
In one embodiment, thirty-three rats were randomly
assigned to receive a vagus nerve cuff electrode or a non-
functional, sham vagus nerve cuff electrode. After recovery
from the surgery implanting the nerve cuff, thirty-one rats
were trained to perform one oftwo operant motortasks using
either their proximalor distal forelimb. After the rats learned
to reliably generate the required movement, VNS waspaired
with the movementseveral hundred times each day for about
five days. For twenty-five of these rats, intracranial micro-
stimulationCMS) was used to quantify the reorganization
in the primary motor cortex about 24 hours after the last
training session. Instead of ICMS,six of the non-stimulated
rats received ischemic motor cortex damage and were
retested to confirm that accurate performance of the task
requires motor cortex. Motor cortex ICMSwasperformed on
tworats that had functional VNSelectrodes and received the
same amount of VNS but received no motor training. An
additional group of eight experimentally naive rats that had
not received motor training or VNS also underwent motor
cortex ICMS.
A comparison of the motor mapsfrom the rats with sham
cuffs to the rats with functional cuffs allows a determination
as to whether pairing VNS with the movements enhances
cortical plasticity. Comparison of the motor maps from rats
that were performing a task during VNS with rats that were
not performing a task during VNSallows a determination as
to whether the motor task was required to generate motor
cortex plasticity.
Forty-one adult, female Sprague-Dawley rats were used in
this experiment. The rats were housed in a 12:12 hour
reversed light cycle environment to increase their daytime
activity levels. During training,the rats’ weights were main-
tained at or above 85% of their normal body weight by
restricting food access to that which they could obtain during
training sessions and supplementing with rat chow afterward
when necessary.
Rats were implanted with a custom-built cuff electrode
prior to training. Stimulating cuffelectrodes were constructed
as previously described. In one embodiment, two TEFLON-
coated multi-stranded platinum iridium wires were coupled
to a section of Micro-Renethane tubing. The wires were
spaced about two mm apart along the length of the tubing. A
region ofthe wireslining the inside circumference ofthe tube
about eight mm long wasstripped ofthe insulation. A cut was
made lengthwise along the tubing to allow the cuff to be
wrapped aroundthe nerve and then closed with silk threads.
This configuration resulted in the exposed wires being
wrapped aroundthe vagusnerve at points separated by about
two mm,while the leads exiting the cuff remained insulated.
These insulated wires were tunneled subcutaneously to the
top of the skull and attached to an external connector. A
second group ofrandomly chosenrats received similar cuffs,
but with silk threads in place of the platinum iridium wires.
In one embodiment,all the steps of the surgeries were the
same regardless of the type of cuff implanted. Rats were
anesthetized using ketamine hydrochloride and xylazine with
supplemental doses provided as needed. After rats were no
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longer responsive to toe pinch,incision sites atop the head and
along the left side of the neck were shaved and cleaned with
betadine and about 70% isopropyl]alcohol. The application of
opthomalic ointment to the eyes prevented corneal drying
during the procedure and a heating pad maintainedtherats’
body temperature at about 37° Celsius (C). Doses of cefo-
taxime sodium anda dextrose/Ringer’s solution were given to
the rats before and during the surgery to prevent infection and
provide nourishment throughout the surgery and recovery.
Bupivicaine injected into the scalp and neck further ensured
that the rats felt no discomfort during surgical procedures. An
initial incision and blunt dissection of the scalp exposed the
lambda landmark on the skull. Fourto five bone screws were
manually drilled into the skull at points close to the lambdoid
suture and over the cerebellum. After an acrylic mount hold-
ing a two-channel connector was attached to the anchor
screws, an incision andblunt dissection of the muscles in the
neck exposedthe left cervical branch ofthe vagus nerve. As in
humans,only the left vagus nerve was stimulated because the
right vagus nerve contains efferents that stimulate the
sinoatrial node and can cause cardiac complication.
In one embodiment, eighteen rats received the platinum
iridium bipolar cuff-electrodes while another thirteen
received the sham cuffs in which silk thread replaced the
platinum iridium wires. Leads (or silk threads) were tunneled
subcutaneously and attached to the two-channel connector
atop the skull. All incisions were sutured and the exposed
two-channel connector encapsulated in acrylic. A topical
antibiotic cream was applied to both incision sites. After
surgery,the rats with silken threads looked identicalto the rats
with wired cuffs after the surgeries. Rats were provided with
amoxicillin (about 5 mg) and carprofen (about one mg) in
tablet form for three days following the surgeries and were
given one week ofrecovery before training began. During the
week of recovery, rats were habituated to having the stimu-
lator cable coupled to the two-channel connector on their
heads. This methodofcuff electrode construction, implanta-
tion, and stimulation delivery has repeatedly been shown to
consistently result in VNSthat persists over the full-term of
the experiment.
In one experiment, rats were trained on either the wheel
spin task (n=10 rats) or the lever press task (n=21 rats).
Training occurred in two daily sessions for five days each
week. Both tasks involved quick movementofthe forelimb in
orderto receive a sugar pellet reward. Rats initiated eachtrial,
but a delay ofat least two seconds was required betweentrials
to allow the rats to eat the sugar pellet. The wheel spin task
required the use of muscles located primarily in the distal
forelimb, especially the wrist, while the lever press task
required the use of the shoulder and the proximal forelimb.
Theinitial shaping procedures were similar for both motor
tasks. In one embodiment, rats were placed in a cage and
allowedto freely explore the area. A tether was coupled to the
rats’ heads to familiarize the animals with the feeling of the
connection. Each time the rats approached the response
device (e.g., the lever or wheel), they received a 45 mg sugar
pellet dispensed into a pellet dish located within the cage.
Restrictions were gradually placed on rewarding the rats’
proximity to the response device until the rats had to be next
to, and then touching, andfinally using the device to receive
the reward. An experimenter conducted shaping procedures
manually. Rats typically took four 30-minute sessions to
becomefamiliarized to the response device. After shaping,all
training sessions were automated using custom-written pro-
grams.
In one embodiment,rats that trained on the wheelspin task
were required to spin a textured wheel below the floor of the
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training cage to receive a sugar pellet reward. Trials were
initiated by the rats, but rewards were spaced at least two
seconds apart by the computer program. In one embodiment,
rats were initially rewarded for spinning the wheel about 3°
within a one-second period when each new stage began. After
about 35 successful spins ofthe wheel, the degree ofrotation
required for a reward increased to about 30°, then about 75°,
and finally about 145°. After about 35 rewardsat the highest
rotational requirement, the rats advancedto the next stage of
training (e.g., more restricted access to the wheel) where they
repeatedall of the levels of increasing rotation again as pre-
viously described. Rats demonstrated a paw preference early
in training and continuedto use that paw for the remainder of
the sessions.
In one embodiment, rats depressed aleverinitially located
inside the training cage to receive a sugar pellet reward. The
training cage was a wire cage with dimensions of approxi-
mately 20 centimeter (cm)x20 cmx20 cm with a Plexiglas
wall opposite the door. In one embodiment,all training ses-
sions other than the shaping sessions were aboutfifteen min-
utes long and occurred about twice daily. Trials were initiated
by therats, but rewards were only givento trials occurring at
least five seconds apart. After receiving about 60 pellets in
about two shaping sessions by pressing the lever, the rats
learned to press the lever twice in an about three-second
period for the same reward. The interval between lever
presses that elicited a reward was reduced from about three
seconds to about two seconds, then about one second, and
finally about 500 milliseconds (ms), with about 15 successful
trials as the criterion for advancing. After successfully press-
ing the lever twice within about 500 msaboutforty-five times,
the lever was gradually withdrawn out of the cage. The lever
was initially located about four cm inside the cage, then
movedto about two cm inside the cage, and then to about 0.5
em, about 1.5 cm, and about 2.0 cm outside of the cage. The
criterion for retracting the lever was about 15 successful
double-lever presses for each position, except for about 0.5
cm outside the cage, which required 30 successfultrials. In
one embodiment,rats reached through a windowin the Plexi-
glas wall that was about one cmxabout seven cm to reach the
lever outside the cage. The edge of the window waslocated
about two cm from the cage wall, while the lever wasoffset so
that the middle of the lever lined up with the edge of the
window furthest from the wall. This arrangementrestricted
the rats so that they could only comfortably press the lever
with their right paw. This aspectofthe task design was impor-
tant for confirming the importanceofthe motor cortex for the
lever press task with motor cortex lesions.
To confirm that accurate performance on the lever press
task requires motor cortex, six rats implanted with the nerve
cuffs and trained on the lever-press task without stimulation
received motorcortex lesions and were retested for about two
days following about one week of recovery. Based on proce-
dures by Fanget al., (2010), the vasoconstrictor endothelin-1
wasusedto selectively lesion the caudal forelimb area of the
motor cortex. Basic surgical procedures for cleaning, anes-
thesia, and post-surgical care were the same as the cuff
implantation surgery. After cleaning the top of the head, an
incision was made longitudinally and a craniotomy was per-
formed over the primary motor cortex caudal forelimb area
contralateral to the trained forelimb (about 2.75 mm to about
-0.75 mm anteroposterior and about 2.25 mm to about 3.75
mm mediolateral, relative to bregma). Endothelin-1 (about
0.33 microliters (uL) of about 0.3 micrograms (ug) mixed in
about 0.1 wL saline) was injected at a depth of about 1.8 mm
using a tapered Hamilton syringe along a grid within the
cramotomyat about 2.5 mm, about 1.5 mm, about 0.5 mm,
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and about -0.5 mm anteroposteriorally, and about 2.5 mm
and about 3.5 mm mediolaterally relative to bregmafora total
of eight sites according to one embodiment. KwikCastsili-
cone gel was used to replace the removed skullcap and the
skin was sutured. The lever press task wasthe only task tested
with motor cortex lesions due to the ease with which the
forelimb usedin the task could berestricted. The lever press
task could not be completed with theleft forelimb because of
the cage design. Lesions were madein the left motor cortex
forcing the rat to try to use its impaired right forelimb to
complete the task. Impairmentsto the distal forelimb accom-
pany impairments to the proximal following motor system
lesions. Additionally, the lesion size covers the entire caudal
forelimb area; therefore, it is expected that impairmentsto the
lever press task would also indicate impairments to the wheel
spin task.
Duringthe final stage of the motortasks, reaching through
a window about 1.2 cm wide and spinning the wheel about
145° within about one second period or pressing the lever
located about two cm outside the cage twice within about 500
ms triggered a food reward and VNS. Stimulations were
delivered approximately 75 ms after the wheel reached 145°
or the levertriggered the secondpress. Rats typically contin-
ued to spin the wheel or press the lever beyond the required
criterion, such that the movements werestill occurring during
VNS.In one embodiment, VNS was always delivered as a
train ofabout 15 pulses at about 30 hertz (Hz). Each about 0.8
milliamps (mA) biphasic pulse was about 100 microseconds
(us) in duration. The train of pulses was about 500 ms in
duration. Previous studies have demonstrated that the ampli-
tude of electroencephalographic measures may be reduced
and neuronal desynchrony may increase during VNS using
the described electrode implantation, which may indicate a
successful stimulation of the vagus nerve. VNS-movement
pairing during the final stage of training continued for one
week (in one embodiment, 10xabout 30 minute sessions for
the wheel-spin task and 10xabout 15 minute sessions for the
lever-press task), delivering around 1,200 total stimulations.
Previous research has shownthat this form ofVNS does not
alter heart rate, blood oxygenationlevel, or ongoing behavior,
suggesting that the stimulation is neither aversive nor reward-
ing to the animals.
In one embodiment, connections andstimulations from the
external stimulator to the rats were identical between rats
implanted with functional or sham VNSelectrode cuffs. The
sham cuffs with silk threads in place ofplatinum iridium leads
did not carry an electrical charge when stimulated. This dif-
ference in the cuffs allows experimenters to remain blind
during training to stimulated and sham rats.
The dayafter the last training session ofVNS movement
pairing, the organization of primary motorcortex contralat-
eral to the trained paw was defined using standard ICMS
mapping procedures. In one embodiment, an additional eight
rats that did not train or receive VNSalso underwent ICMS
proceduresto the left cortex to comparethe effects oftraining
on motor cortex organization. After placing the rat in a ster-
eotaxic frame with a digital readout, a craniotomy was per-
formed to expose the motor cortex. In one embodiment,
parylene-coated tungsten electrodes were inserted to a depth
of about 1,800 micrometers. Stimulation occurred following
a grid with about 500 um spacing. Sequential electrode place-
ments were madeat least onemm apart wherepossible. ICMS
was delivered once per second. In one embodiment, each
stimulation consisted of an about 40 mspulse train of about
ten 200 ts monophasic cathodal pulses delivered at about 286
Hz. Stimulation intensity was gradually increased (from
about 20 to about 200 microamperes (11A)) until a movement
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was observed. If no movement was observed at the maximal
stimulation, then the site was deemed nonresponsive. The
borders ofprimary motor cortex were defined based on unre-
sponsive sites and stopped at the posterior-lateral vibrissae
area, which is knownto overlap the somatosensory cortex.
In one embodiment, motor mapping procedures were con-
ducted with two experimenters, both blind to the experimen-
tal condition of the rat. The first experimenter placed the
electrode and recorded the data for each site. Because the
motor cortex is organized with similar movements often
occurring in the general vicinity of each other, the second
experimenter was kept blind to the electrode placement to
avoid potential biasing. The second experimenter delivered
stimulations while observing which parts of the body moved
in response. Movements wereclassified based on the part of
the body that moved using the threshold stimulation current.
Larger movements were obtained using higher current stimu-
lations and were used when necessary to disambiguate move-
ments too small to confidently classify at threshold levels.
Thefirst stimulation site was placed in an area often resulting
in movementof the lower forelimb. Subsequent stimulation
sites were randomly chosen anddid not extend beyondestab-
lished border (e.g., unresponsive) sites. Movements of the
vibrissae, face, eye, and neck were classified as “head”.
Movementsofthe shoulder, elbow, and upper forelimb,e.g.,
proximal forelimb, were classified as “upper forelimb”.
Movements of the wrist and digits were called “distal fore-
limb”. “Hindlimb”included any movementin the hindlimb of
the rat. Cortical area was calculated by multiplying the num-
berofsites eliciting a response by about 0.25 mm”.Four sites
equal about one mm?.
To confirm that VNSalone does not produce motor cortex
map reorganization, two rats that were never trained to per-
form a motor task were placed into a training cage and
received randomly delivered VNS(e.g., not paired to a spe-
cific movement). Except for the movementpairing, VNS in
this group wasidentical to the groups above. In one embodi-
ment, each animal was passively stimulated for two
30-minute sessions per day with an about two-hour break
between sessions, and repeated for about five days. Within
each session, stimulation occurred for a time from about 8 to
about 16 seconds, giving an average stimulation time ofabout
11.25 seconds. At the end of each session, about 160 stimu-
lations were given, which amounted to about 1,600 stimula-
tions. Animals were ICMS mapped about 24 hours following
the final passive VNSsession.
Rats were shaped to the wheel spin task in about 440.3
sessions andthe leverpresstask in about 440.3 sessions. Rats
reached the last stage of the wheel spin task in about 27+5
sessions and the lever press task in about 8+1 session. The
percent of successfully completed trials on the wheel spin
task on the first day ofVNS paired training was about 77+4%.
The same measurefor the lever press task on thefirst day of
VNSpaired training was about 78+4%. Microelectrode map-
ping techniques were used to determine the organization of
the motorcortex after five days ofVNSpairedtraining on the
last stage. Mapsofthe motor cortex were derived from about
3,595 electrode penetrations (average about 103 sites per
animal).
In all rats tested, the anterior portion of the motor map
generated movements of the rat’s head, including the jaw,
vibrissa, and neck. The middle region of the map generated
movementsofthe forelimb and the posterior region generated
movements of the hindlimb. As in earlier reports, it was
possible to divide the forelimb area into a small rostral region
that is mostly surrounded by head responses and a larger
caudal forelimb area that borders the hindlimb area.
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In one embodiment, the organization of primary motor
cortex wasnot significantly altered by training without VNS.
The average area representing the distal forelimb, proximal
forelimb, head, and hindlimb werenot significantly different
across the naive, wheel spin, or lever press trained rats that
had sham VNScuffs electrodes and received no VNS. As a
result, these three control groups are averaged for group
analyses and referred to as the non-VNSgroup.
In one embodiment, rats that receivedVNSpaired with the
wheel spin task exhibited a significant reorganization of the
motor cortex. In the non-VNSrats, the head and distal fore-
limb occupy approximately the same amountof cortical area
Hindlimb and proximal forelimb comprises a smaller region
of the motor map. Wheel spin/VNSpairing resulted in an
about 15% larger distal forelimb area (about 1.0 mm7), an
about 25% smaller head area (about -1.75 mm), and no
proximalforelimbarea in this particular animal compared to
the naive. These changesin cortical area for the Wheel spin/
VNSpaired group were pronounced when comparedto the
non-VNS group. On average, pairing VNS with the wheel
spin task resulted in an about 32% increase in the cortical area
representing the distal forelimb compared to the non-VNS
group. This increase was accompanied by an about 38%
smaller head area and an about 63% smaller proximal fore-
limb area, but no change in the area devoted to hindlimb.
These results suggest that repeatedly pairing VNS with a
particular movement can generate a specific increase in the
motor cortex representation of that movement.
To confirm that the observedcortical plasticity was specific
to the movement paired with VNS, the reorganization of
motor cortex was documented in rats that received VNS
paired with a lever press task. Since this task primarily
involves movement of the proximal forelimb, an increased
proximalforelimb representation after lever press/VNSpair-
ing was expected. The lever press/VNSrat had about 1600%
(about four mm”) more area devotedto the proximal forelimb
area compared to the naive rat. Pairing VNS with the lever
press movement reduced the head area by about 39% (about
-2.75 mm”) anddistal forelimb area by about 59% (about -4
mm?)in this rat compared to the naive rat. Like the wheel
spin/VNStrainedrat, the lever press/VNSrat had the same
sized hindlimb representation as the naive rat. These
examples suggest that the motor cortex plasticity observed
following VNS-movement pairing may be specific to the
paired movementandnota general effect ofVNS.
On average, rats that received VNS during the lever task
exhibited about 159% increasein the proximal forelimb area
comparedto the non-VNSgroup. Thelever press/VNS group
had an about 23% smaller distal forelimb area and an about
29% smaller head area than the non-VNS group. The most
profound differences were observed between the wheel spin/
VNSrats and the lever press/VNSrats. Although both groups
received identical VNS, wheel spin trained rats had an about
72% larger distal forelimb area than the lever press rats and
the lever press rats had an about 598% larger proximalfore-
limb area compared to the wheel spin trained rats. These
results may demonstrate that VNS-movementpairing can
generate large-scale reorganization ofmotor cortex and con-
firm that the reorganization is specific to the movement
repeatedly paired with VNS.
In one embodiment, VNSwasdelivered at random times in
two rats before documenting the organization ofmotor cortex
using ICMStechniques. Motor cortex in these rats was simi-
lar to naive rats and there was no evidenceofthe reorganiza-
tions that were observed after either the lever press or the
wheel spin movements were paired with VNS.This observa-
tion combinedwith task specificity of the motor cortex plas-
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ticity observedin thetrained rats that receivedVNS suggests
that VNS-movement pairing may be sufficient to generate
motor cortex reorganization.
In one embodiment, there was no difference in the average
stimulation thresholds for the groups receiving movement
pairedVNS and the non-VNSgroup. Thedifferences in aver-
age stimulation thresholds between past studies and the cur-
rent study maybe due to our using a somewhatdeeperlevel of
anesthesia. The rats trained with VNSpaired on the wheel
spin task had an average distal forelimb stimulation threshold
not too different from the wheel spin trained group with sham
VNS cuff electrodes. The VNS paired with lever press
group’s proximal upper forelimb stimulation thresholds was
not considerably different from the lever press group trained
with sham VNScuff electrodes. Similar stimulation thresh-
olds between paired-VNS and non-VNStrained rats demon-
strate that the observed movementrepresentation reorganiza-
tions are not dueto altered levels of excitability in the cortex.
This result is consistent with several papers that have found
cortical representation changes in the motor cortex from
training occurs without ICMSthreshold changes. Morpho-
logical changes, such as synaptogenesis, have been observed
with past motor cortical reorganization accompanyingtrain-
ing and may account fora mechanism ofchange inmovement
paired VNS.
The performance on the lever press task before and after
ischemic motor cortex damage in six rats was compared. In
one embodiment, performance was markedly impaired in
every rat. Average performancefell from 9341% successful
double-tap attempts for the last two days before surgery to
75+5% for the two days of testing conducted after a week of
recovery. This result tends to confirm thatthis task like other
skilled motor tasks may depend on motor cortex for accurate
performance.
The task performance in each group was compared to
confirm that movement paired VNS does not make the task
more difficult. In one embodiment, no behavioral differences
were observed between VNSand sham groups on the wheel
spin task in the total numberofsuccessfultrial, the velocity at
which the wheel was spun, or the percentage of successfully
completedtrials per session. VNS rats showed no impairment
on the lever press task and, in fact, exhibited shorter lever
press intervals andtriple pressed the lever more often than the
sham rats. AlthoughVNSenhanced someaspectsofthe lever
press task, the percent of successful trials and the total num-
ber of successful trials were not different between the VNS
and sham rats. These results mayindicate thatVNSis unlikely
to have enhanced map reorganization by making the task
more difficult.
It was predictedthat repeatedly pairing brief stimulation of
the vagus nerve with a specific movement would result in a
larger representation of that movement in the motor cortex.
As such, about 0.5 sec ofVNS wasdelivered each time rats
used their distal forelimb to rotate a wheel. After several
hundredpairings, the cortical representationofthe distal fore-
limb was markedly larger in these rats comparedto naive rats
and rats that performed the same movements withoutVNS.A
second group of rats was trained on a motor task using a
different part oftheir body to confirm that map reorganization
wasspecific to the movement paired with VNS.PairingVNS
with a lever press task that required the use of the proximal
forelimb resulted in a markedly larger proximal. Impaired
performancein a group ofrats following ischemic lesions to
the caudal forelimb area tends to confirm the involvement of
the motor cortex in this task. The observations that map
expansion wasspecific to the movementpaired withVNS and
that neither of the tasks without VNS nor VNS without the
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task training generated map reorganization indicates that
movementpaired VNSis sufficient to direct mapplasticity.
Pairing VNSwith a motor event generated cortical plastic-
ity comparable to that observed using a similar paradigm in
the auditory system. Presenting a tone with a brief period of
VNScausesa significant expansion ofthe paired tone’s rep-
resentation in the auditory cortex. Presenting tones or VNS
alone did not alter the auditory cortex’s tonotopic organiza-
tion. These two studies suggestthat the plasticity enhancing
mechanisms of event-paired VNS may be shared with the
auditory and motorcortex.
A numberofstudies have reported that training on skilled
motor tasks increases cortical representations for the move-
ments involved. The results disclosed herein do not contradict
these findings, as one of the landmark studies demonstrating
training inducedcortical plasticity using a skilled reaching
task also demonstrated a lack of reorganization for a lever
press task. The lack of observed cortical change following
training on the lever press and wheel spin tasks may be due to
a numberofreasons. The cortical reorganization observed in
a skilled reaching task has beenattributed to the accuracy of
the movements necessary to complete the task which may be
absent in our lever press and wheel spin tasks. There is also a
possibility that the sampling distance of about 500 ium is too
coarse to see cortical changes associated with tasks in the
current study, although this spacing has previously demon-
strated training induced plasticity in the aforementioned
skilled reaching task. Another possibility is the cortical
changes observed following motor and auditory learning
have been shown to be transient while the acquired skill
remains stable over time. The lever press and wheel spin
trained rats were mapped approximately 10 and 20 daysafter
their initial training session, respectively, possibly occurring
after cortical changes associated with training would have
been observed. If this possibility occurred, then the VNS-
paired training may have prolonged or reestablished the
observed changesin the motor cortex organization.
The exact mechanisms by which VNSdirectsplasticity in
motoror sensory cortex are unknown. VNScausesthe release
of several molecules known to enhancecortical plasticity,
including acetylcholine, norepinephrine, serotonin, and brain
derived neurotrophic factor. Perfusing norepinephrine into an
adult cat’s visual cortex produces kitten-like plasticity in a
test ofocular dominanceshifts following monocular depriva-
tion. Serotonin specific neurotoxins and receptor blockers
prevent normalocular dominanceshifts in kittens in monocu-
lar deprivation, implicating the importance of serotonin for
normal plasticity. Another important study showed that
enhancing serotonin release with fluoxetine can stimulate
plasticity in adult cats. Blocking the release of acetylcholine
prevents cortical plasticity and interferes with skill learning
and recovery from brain damage. The use of the muscarinic
antagonist scopolamine blocks the effect ofVNS on sponta-
neousfiring rate in the auditory cortex, further supporting the
influence of VNS on the cholinergic system. Adding brain
derived neurotrophic factor induces plastic changes in ocular
dominanceshifts in adult rats following monocular depriva-
tion. Combining more than oneofthese elements can lead to
greater plasticity than the influence of the elements singu-
larly. The ability of VNS paired with wheel-spin or lever-
press training to produce cortical plasticity supports the
importance ofthe VNStriggered release ofthese molecules in
enhancingcortical plasticity. VNSis likely to generate corti-
cal mapplasticity specific to the associated event through the
synergistic action ofmultipleplasticity enhancing molecules.
The simultaneous presentation ofVNS with a specific sen-
sory or motor event can be sufficient to increase cortical
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representation ofthat movement. As discussed above, a sugar
pellet was used to reward the animal’s behavior immediately
after the completion ofatrial. As a result, VNS wasdelivered
during the behavioral task that finished just a few seconds
prior to the animaleating the pellets. It would not have been
surprising to see an increased representation of the head and
jaw in this study.
In a previous study, our lab demonstrated that changes in
auditory cortex were temporally specific to tones paired with
VNS.Two randomly interleaved tones were presented every
about 15 to about 45 seconds for several thousandtrials to a
rat with only oneofthe tones paired with VNS. The number
of sites responding to the VNSpaired tone increased signifi-
cantly, while the numberofsites for the tone presented within
tens of seconds of the VNSdid not. These observations are
consistent with past studies demonstrating that pairing
nucleus basalis stimulations with tones only alters the tone’s
representations when stimulations occurred within seconds
ofthe tone presentation.
The results disclosed herein demonstrate that the head
representations did not increase because ofVNSjustprior to
chewing. This result indicates that the plasticity enhancing
actions ofVNSare temporally precise, lasting less than about
one or about two seconds. These results demonstrate that
brief pulses of VNS can be used to direct highly specific
plasticity. Additionally, VNS without paired behavioraltrain-
ing did not result in map reorganization, further supporting
our conclusion that the cortical changestriggered byVNSare
enhanced by task specific pairing. Methods for enhancing
plasticity that rely on slow-acting mechanisms may not be as
effective in generating the same accuracy of plasticity as
VNS-pairing. Pharmaceuticals often elevate or diminish cer-
tain neurotransmitters for several hours. Several movements
or sensory events may occur repeatedly during this time,
potentially creating unwantedplasticity. The temporal preci-
sion of the VNS-pairing method for enhancing cortical plas-
ticity should offer advantages in efficiency and efficacy as
compared to methods with less precise actions.
In one embodiment, motor map expansionsdid not accom-
pany enhancedtask performancein rats trained on the VNS
paired wheelspin or lever press tasks. This is not necessarily
at odds with the prediction that event paired VNSincrease
functional recovery through increasing functional plasticity
following cortical damage. Map reorganization has been
shown to be important for enhancing behavioral outcomes
during the learning process (Reedet al., 2011). Rats demon-
strating increased tonotopic representations for low frequen-
cies following paired nucleus basalis stimulation demon-
strated faster learning of a tone discrimination task compared
to controls. However, rats that had already learned the tone
discrimination did not behaviorally benefit from the induced
plasticity. From these results, the authors concludedthat“cor-
tical map expansion plays a majorrole in perceptual learning
but is not required to maintain perceptual improvements”. In
the present disclosure, the rats had already learned the tasks
when they began receiving VNS, otherwise they may have
demonstrated an accelerated learning rate compared to the
sham groups. The enhanced propensity forcortical reorgani-
zation accompanying event-paired VNS may increase reha-
bilitative learning.
Stroke and traumatic brain injury often damage movement-
controlling areas ofthe motor cortex resulting in hemiparesis
or hemiplegia. Following cortical injury, lost motor represen-
tations can partially regenerate in neighboring areas within
motor cortex. The size of the regenerated representationsis
highly correlated with the functional recovery of lost move-
ments, but this recovered area andability is a fraction ofthose
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seen pre-injury. Physical training in healthy animals can
greatly increase cortical representation of the muscles used,
during learning ofthe task, but rehabilitative physicaltraining
in rats after a motor cortical injury is less effective at gener-
ating this increased representation. MovementpairedVNSin
intact rats generates a comparable amountofcortical plastic-
ity in approximately the same amount of time as physical
training. Movementpaired VNSisalso able to enhanceplas-
ticity where plasticity is not observed with training alone.
Since increasedcortical plasticity is related to increased func-
tional recovery following cortical injury, it is possible that
movement pairedVNS could enhancethe recovery ofspecific
motor functions following cortical injury, comparedto reha-
bilitative training alone.
Non-invasive brain stimulation techniques, such as
repeated transcranial magnetic stimulation and transcranial
direct current stimulation, show promise as methods for
inducing better functional recovery with rehabilitative train-
ing following stroke than training alone. These techniques
apply a localized current to the scalp to manipulate electrical
fields in the cortex without the need for surgery or pharma-
ceuticals. These methods are thought to work primarily
through influencing levels of cortical excitability, but also
cause increased levels ofneurotrophic factors, serotonin, and
dopamine. Combining paired-VNS methods with non-inva-
sive brain stimulation may lead to even greater recovery than
either method used alone throughactivating different plastic-
ity enhancing mechanisms.
Periodic VNS is Food and Drug Administration (FDA)
approvedas a safe and effective treatmentof certain types of
refractory epilepsy as well as treatment-resistant depression.
Protocols for treating epilepsy comprise about 30 seconds of
VNSevery about five minutes, 24 hours per day. Periodic
VNSusing a stimulation protocol similar to that used in
treating epilepsy has improved functional recovery in rats
with fluid percussion injury to the cortex. This protocol
requires about 145 timesthe daily current injection compared
to what wasused in the method disclosed herein. The above-
disclosed results tend to demonstrate that motor and auditory
events can be precisely timed with VNS to markedly alter
motor and auditory system organization, respectively. It
seemslikely that therapies using pairedVNS might be a more
effective therapy for increasing functional recovery following
cortical damage.
Selectively pairing VNS has already shown promise in
normalizing abnormalcortical organizations in the treatment
of tinnitus in rats. The overrepresentation of a tone was
reduced by pairing VNS with tones spanning the rats hearing
range except for the tones near the tinnitus frequency. This
eliminated the behavioral correlate oftinnitus in rats for sev-
eral months past the cessation of the treatment. A similar
strategy of pairing VNS with movements may improve the
treatment of disorders related to abnormalrepresentations in
the motor system, such as dystonias. Although the causes are
not fully understood, patients with dystonia demonstrate dis-
turbed cortical inhibition that is improved with the applica-
tion of transcranial magnetic stimulation. Current evidence
supports that reducing the overrepresented motorarea during
these treatments is associated with a reduction in dystonic
symptoms. As disclosed herein, the larger representations
observed from the VNS paired movements were accompa-
nied by smaller nearby cortical representations, such as
movements of the head. Selectively increasing the size of
surrounding muscle representations might decrease the over-
representation of the dystonic muscles. Movement paired
VNSofnon-dystonic, surrounding movements may decrease
the overrepresentation of the dystonic muscles. Thestrategic
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pairing of non-dystonic movements with VNS provides a
novel potential therapy to treat focal dystonia.
clinical and pre-clinical data has been collected to support
the effectiveness of the tinnitus therapy and parameters.
Selection ofthe vagus nervefor stimulation is not arbitrary.
The vagus nerve producesspecific effects when stimulated at
a specific time relative to a physical task. The peripheral
nervous system, central nervous system including the brain
and spinal cord are typically used by others as therapeutic
stimulation locations. The choice of stimulation location
largely determines the behavioral and neurophysiologic out-
come. Even though similar neural populations are activated
by input from two different locations, the manner in which
they are activated, for example, the pattern of activity gener-
ated within the neuron population may depend on the time
course ofactivation, release ofone or more neuromodulators,
attention state, etc. The neurophysiological consequences
therefore are bound to be different. Given the large (and
unknown) numberofvariables that can influence the activa-
tion ofa given neural population, the mechanismsarelikely to
be complex and unpredictable. There is no calculus to deter-
mine which locations may produce which effects. Finding a
location that producesa given effect can only be done experi-
mentally. It is not valid to suggest that stimulation at one
location makesit obvious to stimulate at a different location,
even ifthe goalis to stimulate the same population ofneurons.
The same canbe said for stimulation parameters. Ata given
stimulation location, stimulation according to one set of
parameters may not necessarily produce the same(orsimilar)
effects as a stimulation according to another set of param-
eters. The frequency of stimulation, the current amplitude of
stimulation, the duration ofeach stimulation, the waveform of
stimulation, as well as other stimulation parameters can
changethe results of stimulation.
Our experiments have shown that the effect generated by
VNSpairing is very short, less than 15 seconds.A first tone at
a first frequency whenpaired withVNSgenerated an increase
in the numberofneuronsthat respondto the paired frequency.
A second unpaired tone at a second frequency, played 15
seconds after the paired VNSdid not show a corresponding
increase in the numberofneuronsthat respond to the second
frequency. Nothing in the prior art indicates this kind of
precise timing requirement.
Similarly, we have performed experiments in which mul-
tiple tones at a given frequency were paired with VNS and
given 30 seconds apart. This was donein the tinnitus study
(Engineeret al., 2011) in whichVNSwaspaired with each of
the randomly interleaved tones every 30 seconds (e.g., 1.3
kilohertz (kHz)+VNS,then wait for 30 seconds, then give 6.3
kHz+VNS,and then wait for 30 seconds and so on). The tones
were selected such that they surrounded the tinnitus fre-
quency and the tinnitus frequency itself was excluded. The
idea wasto shrink the representation ofthe tinnitus frequency
thereby restoring the map and synchronousactivity back to
normal. When the same tones were presented eight seconds
apart, the effect was less than if the tones were presented 30
seconds apart, which was surprising.
To cite another example, we have performed a series of
experiments where a tone is repeatedly paired with a foot-
shockto establish a conditioned fear response. Subsequently,
when the tone was presented without a foot-shock, the rat
would freeze, anticipating a foot shock. If the tone, without
the foot-shock, is then presented repeatedly, the fear caused
by the tone would eventually be extinguished, undoing the
conditioning. By pairing the tone (without the foot-shock)
withVNS,the fear is extinguished much more quickly. How-
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ever, presenting the tone by itself and then giving VNS min-
utes later, the fear is extinguished at the normalrate.
Further experiments have demonstrated the effect of the
described therapy. VNS paired with a movement improves
motor performance in a rat model of ischemic stroke. VNS
paired withmovement improves a motor deficit several weeks
after an ischemic lesion. VNS delivered two hours after reha-
bilitation did not show any significant difference from reha-
bilitation alone.
These results demonstrate that the precise timing between
VNSand the event as well as the interval separating the
VNS-event pairings appear to be important for inducing
highly specific plasticity.
Neurostimulation does not behavein a predictable fashion.
Different stimulation locations produce different results,
even when both locations are cranial nerves. For example,
synchronization in the cerebral cortex is a manifestation of
epilepsy. Stimulating the vagus nerve causes desynchroniza-
tion of the cortex neurons, which has been proposed as a
potential mechanism for how vagus stimulation prevents an
epileptic seizure. Stimulation ofthe trigeminal nerve, another
cranialnerve, causes desynchronization as well. To determine
whetherthe plasticity induced byVNSis specific to the vagus
nerve, we paired stimulation ofthe trigeminal nerve with a 19
kHz tone. However, when wepaired trigeminal stimulation
with a tone, in the same way wepaired VNSwith a tone, we
did not observe anyplasticity that was specific to the paired
tone. Pairing the trigeminal stimulation with a tone at a given
frequency did not changethe response to that frequency even
thoughit caused desynchronizationlike in the previous study.
Each stimulation location is unique across the full range of
effects. It appears that VNS may be uniquely suited to direct
cortical plasticity and suggests that the vagus nerveis likely a
key conduit by which the autonomic nervous system informs
the central nervous system of important stimuli.
Both VNSpairing and nucleus basalis stimulation (NBS)
pairing have been shown to change the numberof neurons
respondingto a paired frequency. To be effective, the current
amplitude parameter of the stimulation for VNS pairing is
more than twice the current amplitude used for NBSpairing.
There is an important difference between the neuromodula-
tors released by NBSfrom those released by VNS,so signifi-
cant differences between the results of NBS and VNSare
expected.
Another experiment demonstrated that pairing a single
tone at a specified frequency with VNSincreased the number
ofneurons responding notonly to that frequency but to close
frequencies, e.g., increased the bandwidth comparedto con-
trol rats. For NBSpairing, the bandwidth was not signifi-
cantly different from control rats. Unlike VNS pairing, NBS
pairing is highly invasive and may be unsuitable to provide a
practical therapeutic benefit. Similar results in one circum-
stance cannotbe extendedto predict similar results in another,
even slightly different, circumstance. Different stimulation
parameters have to be used for effective VNS pairing and
NBSpairing.
Because ofthe specific neurotransmitter mechanisms that
generate the specific plasticity required for the described
therapies, some drugs may reduce the effectiveness. Musca-
rinic antagonists, norepinephrine blockers that are centrally
acting, norepinephrine uptake inhibitors, nicotinic antago-
nists, Selective serotonin reuptake inhibitors, drugsthat block
serotonin and drugs that block dopamine mayall reduce the
effectiveness of the paired VNStherapies.
Noneofthe description in the present application should be
read as implyingthat any particular element, step, or function
is an essential element that must be included in the claim
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scope: the scope ofpatented subject matter is defined only by
the allowed claims. Moreover, none of these claims is
intended to invoke paragraph six of 35 U.S.C. section 112
unless the exact words “means for” are followed by a parti-
ciple. The claimsas filed are intended to be as comprehensive
as possible, and no subject matter is intentionally relin-
quished, dedicated, or abandoned.
At least one embodimentis disclosed and variations, com-
binations, and/or modifications of the embodiment(s) and/or
features ofthe embodiment(s) madeby a person having ordi-
nary skill in the art are within the scope of the disclosure.
Alternative embodiments that result from combining, inte-
grating, and/or omitting features of the embodiment(s) are
also within the scope of the disclosure. Where numerical
rangesor limitations are expressly stated, such express ranges
or limitations should be understoodto includeiterative ranges
or limitations of like magnitude falling within the expressly
stated ranges or limitations (e.g., from about 1 to about 10
includes, 2, 5, 4, etc.; greater than 0.10 includes 0.11, 0.12,
0.15, etc.). For example, whenever a numerical range with a
lower limit, R,, and an upper limit, R,, is disclosed, any
numberfalling within the range is specifically disclosed. In
particular, the following numbers within the range are spe-
cifically disclosed: R=R,+k*(R,-R,), wherein k is a variable
ranging from 1 percent to 100 percent with a 1 percent incre-
ment, i.e., k is 1 percent, 2 percent, 5 percent, 4 percent, 5
percent, ... , 50 percent, 51 percent, 52 percent, ..., 75
percent, 76 percent, 77 percent, 78 percent, 77 percent, or 100
percent. Moreover, any numerical range defined by two R
numbersas defined in the aboveis also specifically disclosed.
Useofthe term “about” means+10% ofthe subsequent num-
ber, unless otherwise stated herein. Use of the term “option-
ally” with respect to any element of a claim means that the
element is required, or alternatively, the element is not
required, both alternatives being within the scope of the
claim. Use ofbroader terms such as comprises, includes, and
having should be understoodto provide support for narrower
terms such as consisting of, consisting essentially of, and
comprised substantially of. Accordingly, the scope ofprotec-
tion is not limited by the description set out above butis
defined by the claims that follow, that scope including all
equivalents ofthe subject matter ofthe claims. Each and every
claim is incorporated as further disclosure into the specifica-
tion and the claims are embodiment(s) of the present disclo-
sure. The discussion of a reference in the disclosureis not an
admissionthatit is prior art, especially any reference that has
a publication date after the priority date of this application.
The disclosure ofall patents, patent applications, and publi-
cations cited in the disclosure are hereby incorporated by
reference, to the extent that they provide exemplary, proce-
dural, or other details supplementary to the disclosure.
With reference to FIG. 16, a response timing control sys-
tem, in accordance with an embodiment, is shown. The
response timing control system includes a response timing
control 138. The response timing control 138 is communica-
bly connected to the neural stimulation system 118 and a
simultaneous event monitor 140. The response timing control
138 receives timing instructions from the event monitor 140
and provides timing instructions to the neural stimulation
system 118, so that the stimulation and training occur simul-
taneously. Becausethe stimulation 1s generated in response to
an event, the stimulation will generally lag the event by some
finite time delta t. In cases where there is an event precursor
that can be monitored, the timing can be made moreexact.
With reference to FIG. 17, a graph showsa possible timing
relationship between a monitored event and a nerve stimula-
tion.
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With reference to FIG. 18, a closed loop timing control
system, in accordance with an embodiment, is shown. The
closed loop timing control system includes a closed loop
timing control 144. The closed loop timing control 138 is
communicably connected to the neural stimulation system
108 and a sensor 146. The dosed loop timing control 144
receives timing instructions from the sensor 146 and provides
timing instructions to the neural stimulation system 118, so
that the stimulation and training occur simultaneously.
With reference to FIG. 19, a graph showsa possible timing
relationship between a sensed training event and a neural
stimulation is shown.
While several embodiments have been provided in the
present disclosure, it should be understoodthat the disclosed
systems and methods might be embodied in many other spe-
cific forms without departing from the spirit or scope of the
present disclosure. The present examples are to be considered
as illustrative and notrestrictive, and the intention is not to be
limited to the details given herein. For example, the various
elements or components may be combined or integrated in
another system or certain features may be omitted, or not
implemented.
In addition, techniques, systems, subsystems, and methods
described andillustrated in the various embodiments as dis-
crete or separate may be combinedor integrated with other
systems, modules, techniques, or methods without departing
from the scope ofthe present disclosure. Other items shown
or discussed as coupledordirectly coupled or communicating
with each other may beindirectly coupled or communicating
through someinterface, device, or intermediate component
whether electrically, mechanically, or otherwise. Other
examples of changes, substitutions, and alterations are ascer-
tainable by oneskilled in the art and could be made without
departing from the spirit and scope disclosed herein.
Whatis claimedis:
1.A method ofimproving motordeficits in a stroke patient,
comprising:
assessing a stroke patient’s motordeficits;
determining therapeutic goals for the patient, based on the
patient’s motordeficits;
selecting one or more therapeutic tasks based on the thera-
peutic goals;
observing repetitive performances by the patient of the
selected therapeutic task;
stimulating the vagus nerve of the patient with an
implanted neurostimulator that delivers pulse trains of
electrical stimulation energy to a vagus nerve while the
patient is performing a movementofthe selected thera-
peutic task;
terminating the stimulation ofthe vagus nerve so that there
is no stimulation between movementexecution; and
improving the patient’s motordeficits,
wherein the action of stimulating the vagus nerve of the
patient further comprises determining respective begin-
nings of performances of the selected therapeutic task,
and applying the pulse trains to the vagus nerve based on
the determined beginnings of the performances, and
wherein the stimulation pulsetrains begin after the begin-
ning of the respective selected therapeutic tasks,
wherein the vagus nerve stimulation pulse trains end
prior to the end of the respective selected therapeutic
tasks, and wherein the vagus nerve stimulation pulse
train is not presented between performances of the
selected therapeutic task.
2. The method ofclaim 1, wherein the pulsetrains are about
500 milliseconds in duration.
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3. The methodofclaim 1, wherein the pulse trains have an
amplitude of about 0.8 milliamperes.
4. The method of claim 1, wherein a therapeutic task level
is selected for each therapeutic task and the therapeutic task
level may be changed betweentherepetitive performances.
5. A method ofimproving motordeficits in a stroke patient,
comprising:
assessing a stroke patient’s motordeficits;
determining therapeutic goals for the patient, based on the
patient’s motordeficits;
selecting a therapeutic task based on the therapeutic goals;
detecting motion during repetitive performances by the
patient of the selected therapeutic task;
automatically stimulating a vagus nerve ofthe patient with
an implanted neurostimulator that delivers pulse trains
of electrical stimulation energy to the vagus nerve when
a predetermined motionis detected;
ending the stimulation ofthe vagusnerveso that there is no
stimulation between the performances; and
improving the patient’s motor deficits,
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wherein the action of stimulating the vagus nerve of the
patient further comprises determining respective begin-
nings of performances of the selected therapeutic task,
and applying the pulse trains to the vagus nerve based on
the determined beginnings of the performances, and
wherein the stimulation pulsetrains begin after the begin-
ning of the respective selected therapeutic tasks,
wherein the vagus nerve stimulation pulse trains end
prior to the end of the respective selected therapeutic
tasks, and wherein the vagus nerve stimulation pulse
train is not presented between performances of the
selected therapeutic task.
6. The method ofclaim 5, wherein the pulse trains are about
500 milliseconds in duration.
7. The method ofclaim 5, wherein the pulse trains have an
amplitude of about 0.8 milliamperes.
8. The method of claim 5, wherein the motion is detected
by detecting change in color of the object by a camera.
* * * * *
